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Background:  In heart failure, high systemic vascular resistance index (SVRI) and low cardiac index (CI) predicts poor outcomes. 
Associations between catheter-measured hemodynamic variables and major adverse events in adults with Fontan circulation have never 
been examined.
methods:  Retrospective review of cardiac catheterization data in 60 adult Fontan patients between 2002-2014 was conducted. Measured 
variables included central venous pressure (CVP), CI, and SVRI. The relationship between hemodynamic variables and major adverse 
events (death or heart transplant) was examined using survival analysis. VAS score (1 point each for varices, ascites, splenomegaly), a 
surrogate for signs of portal hypertension, was compared to assess potential systemic vasodilatory effect.
results:  60 post-Fontan patients (85% systemic left ventricle, 40% atriopulmonary Fontan, age 28.0±7.2 years, time since Fontan 
operation 21.9±5.6 years) were analyzed. 18 experienced events: 10 deaths, 8 transplants. Comparing event vs. non-event group, 
mean CI was 2.8±0.9 vs. 2.4±0.5L/min/m2 (p=0.03), SVRI was 1983±1009 vs. 2381±828 dynes*s/cm5/m2, and CVP was 18.6±6.5 vs. 
16.1±4.3mmHg. VAS score≥2 was present in 44% vs. 17% (p=0.002). Prevalence of relevant medication use was not different: digoxin 
(p=0.5), spironolactone (p=0.7), ACE-inhibitor (p=0.8), diuretics (p=0.8), hydralazine (p=0.3). After adjusting for potential confounders, there 
was no significant association between the hemodynamic variables and adverse events: CI with hazard ratio (HR)=1.3 [95%CI 0.7-2.2], 
p=0.3; SVRI with HR=1.0, CVP with HR=1.0.
Conclusion:  Adult Fontan patients who have major adverse events have a distinct hemodynamic phenotype. Alterations of CI, SVRI, 
or CVP typically seen an advanced heart failure were not seen in failing adult Fontan patients. Notably, a trend toward increased CI 
and reduced SVRI was observed in the event group. Further study is needed to understand the etiology of these distinct hemodynamic 
phenotypes.
